PUCHHEIM, Germany & BALGACH, Switzerland--(BUSINESS WIRE)--Sloning Biotechnology the innovator and technological leader in the emerging gene synthesis market is pleased to announce a distribution partnership with Microsynth the leading provider of custom oligonucleotide synthesis and DNA sequencing to the Swiss market.
Microsynth will exclusively market and sell Sloning´s gene synthesis service (Slonomics™) and the product family of mutant libraries (Slonomax™) in Switzerland.
